UAB Liukrena secures contract for Antineoplastic agents - Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab) and/or (Panitumumab)

Lithuania, Jan. 22 -- Lithuania based UAB Liukrena has secured contract from Valstybine ligoniu kasa prie Sveikatos apsaugos ministerijos for Antineoplastic agents - Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab) and/or (Panitumumab). The value of the contract is worth 83071170 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....